Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2022

13-09-2022 | Infliximab | Multicenter Seminars: IBD (MUSE: IBD)

Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis

Authors: Tenzin Choden, Mia Yeager, Russell D. Cohen

Published in: Digestive Diseases and Sciences | Issue 11/2022

Login to get access

Excerpt

A 56-year-old man with a history of advanced metastatic melanoma was evaluated for ongoing diarrhea and urgency. Diarrhea, described as multiple loose bowel movements a day with occasional blood, had started 5 years earlier after undergoing immunotherapy with four cycles of ipilimumab. He had no prior history of gastrointestinal issues but did have a family history of a mother with ulcerative colitis. Though symptoms improved without completely abating after ipilimumab was discontinued, he resumed immunotherapy with nivolumab to complete ten total cycles. Diarrhea recurred and worsened with up to 10 bowel movements a day, eventuating in hospitalization for dehydration with acute kidney injury, at which time a computerized tomography (CT) scan showed diffuse colitis. He was treated with intravenous steroids and discharged on a prednisone taper, but continued to have milder, ongoing loose bowel movements with urgency. …
Literature
Metadata
Title
Checking Out the Associations Between Inflammatory Bowel Disease and Checkpoint Inhibitor Colitis
Authors
Tenzin Choden
Mia Yeager
Russell D. Cohen
Publication date
13-09-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07668-5

Other articles of this Issue 11/2022

Digestive Diseases and Sciences 11/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.